Oxford at forefront of medical cannabis researchCNBC.com.
The oldest university in England will be teaming up with private equity company Kingsley Capital Partners which will provide up to £10 million (US$12.5 million) in initial investment, which will be funded through its new biopharmaceutical firm Oxford Cannabinoid Technologies.
At present, cannabis is not permitted in the United Kingdom despite calls for its legislation; however, the cannabis-based ingredient cannabidiol has recently been classified as a medicine. In 2016, a cross-party group of UK politicians called upon the government to legalise medical cannabis, stating that there was a sound evidence base that revealed cannabis could be effective for a number of chronic conditions.
Full report on the CNBC site